Evidence map›Paper›PMID 41333136›Full record

ArticleJugan geon-gang gwa jilbyeong2023

[The Outbreak and Response of Coronavirus Disease 2019 in Gyeongbuk Area (Daegu, Gyeongbuk) in 2022].

Chungmin Park, Hanul Park, Seong Ju Choi, Yeon Haw Jung, Junsuk Son, Jimin Lee, Hwa Bae, Mina Lim, Youkyoung Kim, Taejong Son

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Jugan geon-gang gwa jilbyeong, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chungmin Park질병관리청 경북권질병대응센터 감염병대응과.
Hanul Park질병관리청 경북권질병대응센터 감염병대응과.
Seong Ju Choi질병관리청 경북권질병대응센터 감염병대응과.
Yeon Haw Jung질병관리청 경북권질병대응센터 감염병대응과.
Junsuk Son질병관리청 경북권질병대응센터 감염병대응과.
Jimin Lee질병관리청 경북권질병대응센터 감염병대응과.
Hwa Bae대구광역시 보건의료정책과.
Mina Lim경상북도 감염병관리과.
Youkyoung Kim경상북도 감염병관리과.
Taejong Son질병관리청 경북권질병대응센터 감염병대응과.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report analyzed the current status of coronavirus disease 2019 (COVID-19) confirmed cases and deaths reported in the Gyeongbuk region during 2022, the current status of COVID-19 outbreaks and actions in infection vulnerable facilities. The purpose of this report is to establish a COVID-19 quarantine policy strategy and provide evidence for the future epidemic of infectious diseases. In 2022, there were 2,557,128 confirmed cases in the Gyeongbuk region and 3,283 deaths. In the total number of confirmed cases and deaths, females accounted for a slightly higher proportion than males. By age, the number of confirmed cases was 40-49 years old (14.3%, 365,357 cases), and the number of deaths was the highest at 80 years of age or older with 2,103 cases (64.1%, fatality rate 2.2%). The incidence rate per 100,000 population was higher in Daegu, but the fatality rate was higher in Gyeongsangbuk-do. Of the deaths, the major underlying diseases were shown circulatory system diseases (63.4%), mental diseases such as dementia/depression (36.6%), and endocrine and metabolic diseases such as diabetes/thyroid diseases (29.6%) from the highest. There were also differences in quarantine policies among the three epidemic periods of the Omicron variant in 2022. As a nationwide epidemic occurred due to the dominance of the Omicron variant, which has higher transmission power than the delta variant, the number of confirmed cases in the Gyeongbuk region also increased significantly. The number of deaths in people aged over 60 also increased, mainly in vulnerable facilities to infection.

Indexed as

Confirmed casesCOVID-19Death caseFacility vulnerable to infectionGyeongbuk region

Identifiers

PMID41333136
PMCPMC12480411

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.